-
公开(公告)号:US11986450B2
公开(公告)日:2024-05-21
申请号:US17735368
申请日:2022-05-03
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
公开(公告)号:US20220280467A1
公开(公告)日:2022-09-08
申请号:US17735368
申请日:2022-05-03
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
3.
公开(公告)号:US20210196728A1
公开(公告)日:2021-07-01
申请号:US17130580
申请日:2020-12-22
Applicant: National Jewish Health
Inventor: Preston E. Bratcher , Pamela L. Zeitlin
IPC: A61K31/558 , A61K31/47 , A61K31/4155 , A61K31/443 , A61K31/404 , A61K31/4439 , A61K31/352 , A61K31/502 , A61P11/00 , A61K45/06
Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
-
公开(公告)号:US20210030706A1
公开(公告)日:2021-02-04
申请号:US16933191
申请日:2020-07-20
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
公开(公告)号:US20250009700A1
公开(公告)日:2025-01-09
申请号:US18638264
申请日:2024-04-17
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
6.
公开(公告)号:US20240342192A1
公开(公告)日:2024-10-17
申请号:US18607971
申请日:2024-03-18
Applicant: National Jewish Health
Inventor: Preston E. Bratcher , Pamela L. Zeitlin
IPC: A61K31/558 , A61K31/352 , A61K31/404 , A61K31/4155 , A61K31/443 , A61K31/4439 , A61K31/47 , A61K31/502 , A61K45/06 , A61P11/00
CPC classification number: A61K31/558 , A61K31/352 , A61K31/404 , A61K31/4155 , A61K31/443 , A61K31/4439 , A61K31/47 , A61K31/502 , A61K45/06 , A61P11/00
Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
-
公开(公告)号:US10751315B2
公开(公告)日:2020-08-25
申请号:US16116409
申请日:2018-08-29
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
8.
公开(公告)号:US11963965B2
公开(公告)日:2024-04-23
申请号:US17130580
申请日:2020-12-22
Applicant: National Jewish Health
Inventor: Preston E. Bratcher , Pamela L. Zeitlin
IPC: A61K31/558 , A61K31/352 , A61K31/404 , A61K31/4155 , A61K31/443 , A61K31/4439 , A61K31/47 , A61K31/502 , A61K45/06 , A61P11/00
CPC classification number: A61K31/558 , A61K31/352 , A61K31/404 , A61K31/4155 , A61K31/443 , A61K31/4439 , A61K31/47 , A61K31/502 , A61K45/06 , A61P11/00
Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
-
公开(公告)号:US11351141B2
公开(公告)日:2022-06-07
申请号:US16933191
申请日:2020-07-20
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
公开(公告)号:US20190083440A1
公开(公告)日:2019-03-21
申请号:US16116409
申请日:2018-08-29
Applicant: National Jewish Health
Inventor: Brian J. Day , Preston E. Bratcher
Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
-
-
-
-
-
-
-
-
-